Literature DB >> 26337998

Globalization of Chagas Disease Burden and New Treatment Perspectives.

Roberto Kalil-Filho1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26337998     DOI： 10.1016/j.jacc.2015.07.024

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  5 in total

1.  Blood Gene Signatures of Chagas Cardiomyopathy With or Without Ventricular Dysfunction.

Authors:  Ludmila Rodrigues Pinto Ferreira; Frederico Moraes Ferreira; Helder Imoto Nakaya; Xutao Deng; Darlan da Silva Cândido; Lea Campos de Oliveira; Jean-Noel Billaud; Marion C Lanteri; Vagner Oliveira-Carvalho Rigaud; Mark Seielstad; Jorge Kalil; Fabio Fernandes; Antonio Luiz P Ribeiro; Ester Cerdeira Sabino; Edecio Cunha-Neto
Journal:  J Infect Dis       Date:  2017-02-01       Impact factor: 5.226

Review 2.  Chagas Cardiomyopathy in Latin America Review.

Authors:  Jefferson Luis Vieira; Fábio Rocha Fernandes Távora; Maria Gyslane Vasconcelos Sobral; Glauber Gean Vasconcelos; Germana Porto Linhares Almeida; Juliana Rolim Fernandes; Laura Leite da Escóssia Marinho; Daniel Francisco de Mendonça Trompieri; João David De Souza Neto; Juan Alberto Cosquillo Mejia
Journal:  Curr Cardiol Rep       Date:  2019-02-12       Impact factor: 3.955

3.  Integration of miRNA and gene expression profiles suggest a role for miRNAs in the pathobiological processes of acute Trypanosoma cruzi infection.

Authors:  Ludmila Rodrigues Pinto Ferreira; Frederico Moraes Ferreira; Laurie Laugier; Sandrine Cabantous; Isabela Cunha Navarro; Darlan da Silva Cândido; Vagner Carvalho Rigaud; Juliana Monte Real; Glaucia Vilar Pereira; Isabela Resende Pereira; Leonardo Ruivo; Ramendra Pati Pandey; Marilda Savoia; Jorge Kalil; Joseli Lannes-Vieira; Helder Nakaya; Christophe Chevillard; Edecio Cunha-Neto
Journal:  Sci Rep       Date:  2017-12-21       Impact factor: 4.379

4.  Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.

Authors:  Augusto E Bivona; Andrés Sánchez Alberti; Marina N Matos; Natacha Cerny; Alejandro C Cardoso; Celina Morales; Germán González; Silvia I Cazorla; Emilio L Malchiodi
Journal:  PLoS Negl Trop Dis       Date:  2018-03-30

5.  Post hoc analyses of SHIFT and PARADIGM-HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: "Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial" by Bocchi et al.

Authors:  Felix J A Ramires; Felipe Martinez; Efraín A Gómez; Caroline Demacq; Claudio R Gimpelewicz; Jean L Rouleau; Scott D Solomon; Karl Swedberg; Michael R Zile; Milton Packer; John J V McMurray
Journal:  ESC Heart Fail       Date:  2018-10-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.